منابع مشابه
World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease
INSULIN RESISTANCE: NEW CONCEPTS—Gerald Reaven (Stanford, CA) opened the meeting with a discussion of the implications of insulin resistance and of the interrelationships between hyperinsulinemia, hypertension, and cardiovascular disease (CVD). In his studies, insulin resistance is estimated from the steady-state plasma glucose (SSPG) during infusion of somatostatin, insulin, and glucose. In a ...
متن کاملCell Therapy in Cardiovascular Disease
Recently, cell therapy has sparked a revolution in ischemic heart disease that will in the future help clinicians to cure patients. Earlier investigations in animal models and clinical trials have suggested that positive paracrine effects such as neoangiogenesis and anti-apoptotic can improve myocardial function. In this regard the Royan cell therapy center designed a few trials in collaborat...
متن کاملCardiovascular Effects of Acute Organophosphate Poisoning
Background:Cardiovascular effects of acute organophosphate (OP) poisoning are common. This study was aimed to assess the cardiovascular effects of OP poisoned patients in Nepal. Methods:This was a prospective hospital-based cross-sectional study of 115 acute OP poisoned patients presenting in emergency department of a tertiary care teaching hospital of central Nepal during November 2008 to Octo...
متن کاملThe Influence of Acute Kidney Injury on Acute Cardiovascular Disease.
UNLABELLED Acute kidney injury (AKI) is an important issue in the management of acute cardiovascular diseases. The risk, injury, failure, loss of kidney function, and end-stage renal failure (RIFLE) criteria, and acute kidney injury network (AKIN) criteria have been proposed to stage and predict the outcomes of patients with AKI. In this article, we review AKI in the context of a variety of acu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2018
ISSN: 0195-668X,1522-9645
DOI: 10.1093/eurheartj/ehy329